Literature DB >> 31640086

Overexpression of P4HB is correlated with poor prognosis in human clear cell renal cell carcinoma.

Zhenpeng Zhu1,2,1, Anbang He1,2,1, Tongde Lv1,2, Chunru Xu1,2, Lanruo Lin3, Jian Lin1,2.   

Abstract

Prolyl 4-hydroxylase, beta polypeptide (P4HB) protein has been found to be associated with tumorigenesis in many types of tumor, However, the relationship between P4HB and clear cell renal cell carcinoma (ccRCC) has not been clarified. In this study, we focus on the correlation between P4HB expression and ccRCC. Through the Cancer Genome Atlas (TCGA) database, Gene Expression Omnibus (GEO) database, our database and immunohistochemical (IHC) staining. Compared with adjacent normal tissues, both the mRNA and protein levels of P4HB in ccRCC tissues were enhanced. The Kaplan-Meier survival analysis showed that high expression of P4HB is correlated with poor prognosis in both TCGA database and our own database. Multivariate survival analysis and Univariate analysis showed that P4HB expression and age are significantly correlative with poor prognose. All the results indicated that P4HB is correlated with poor prognosis in human clear cell renal cell carcinoma.

Entities:  

Keywords:  GEO; P4HB; TCGA; ccRCC

Mesh:

Substances:

Year:  2019        PMID: 31640086     DOI: 10.3233/CBM-190450

Source DB:  PubMed          Journal:  Cancer Biomark        ISSN: 1574-0153            Impact factor:   4.388


  9 in total

1.  Targeted Inhibition of P4HB Promotes Cell Sensitivity to Gemcitabine in Urothelial Carcinoma of the Bladder.

Authors:  Xiaoming Wang; Yunjin Bai; Facai Zhang; Yubo Yang; Dechao Feng; Ao Li; Zhiqiang Yang; Dengxiong Li; Yin Tang; Xin Wei; Wuran Wei; Ping Han
Journal:  Onco Targets Ther       Date:  2020-09-28       Impact factor: 4.147

2.  An oncogenic JMJD6-DGAT1 axis tunes the epigenetic regulation of lipid droplet formation in clear cell renal cell carcinoma.

Authors:  Jin Zhou; Jeremy M Simon; Chengheng Liao; Cheng Zhang; Lianxin Hu; Giada Zurlo; Xijuan Liu; Cheng Fan; Austin Hepperla; Liwei Jia; Vanina Toffessi Tcheuyap; Hua Zhong; Roy Elias; Jin Ye; W Mike Henne; Payal Kapur; Deepak Nijhawan; James Brugarolas; Qing Zhang
Journal:  Mol Cell       Date:  2022-06-27       Impact factor: 19.328

3.  WHSC1 Promotes Cell Proliferation, Migration, and Invasion in Hepatocellular Carcinoma by Activating mTORC1 Signaling.

Authors:  Jingjing Dai; Longfeng Jiang; Lei Qiu; Yuyun Shao; Ping Shi; Jun Li
Journal:  Onco Targets Ther       Date:  2020-07-20       Impact factor: 4.147

4.  Identification of an independent autophagy-gene prognostic index for papillary renal cell carcinoma.

Authors:  Xiyi Wei; Wei Wang; Hongye Wang; Yamin Wang; Yichun Wang; Guangyao Li; Chengjian Ji; Xiaohan Ren; Ninghong Song; Chao Qin
Journal:  Transl Androl Urol       Date:  2020-10

5.  Prognostic Value and Potential Biological Functions of CLDN8 in Patients with Clear Cell Renal Cell Carcinoma.

Authors:  Zhenpeng Zhu; Chunru Xu; Lanruo Lin; Tongde Lv; Tianyu Cai; Jian Lin
Journal:  Onco Targets Ther       Date:  2020-09-15       Impact factor: 4.147

6.  Key genes associated with prognosis and metastasis of clear cell renal cell carcinoma.

Authors:  Tingting Zhong; Zeying Jiang; Xiangdong Wang; Honglei Wang; Meiyi Song; Wenfang Chen; Shicong Yang
Journal:  PeerJ       Date:  2022-01-04       Impact factor: 2.984

7.  Identification of immunization-related new prognostic biomarkers for papillary renal cell carcinoma by integrated bioinformatics analysis.

Authors:  Ping Wu; Tingting Xiang; Jing Wang; Run Lv; Shaoxin Ma; Limei Yuan; Guangzhen Wu; Xiangyu Che
Journal:  BMC Med Genomics       Date:  2021-10-07       Impact factor: 3.063

8.  Identification and validation of P4HB as a novel autophagy-related biomarker in diabetic nephropathy.

Authors:  Fang Bai; Kuipeng Yu; Yanjiang Yang; Yimeng Zhang; Lin Ding; Xin An; Feng Feng; Nan Sun; Jiahui Fan; Lei Liu; Huimin Yang; Xiangdong Yang
Journal:  Front Genet       Date:  2022-09-26       Impact factor: 4.772

9.  High expression levels of DEF6 predicts a poor prognosis for patients with clear cell renal cell carcinoma.

Authors:  Zhen-Peng Zhu; Lan-Ruo Lin; Tong-De Lv; Chun-Ru Xu; Tian-Yu Cai; Jian Lin
Journal:  Oncol Rep       Date:  2020-08-18       Impact factor: 3.906

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.